.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Formulary management
  • Uncover prior art in abandoned patent applications and expired patents

► Plans and Pricing

DrugPatentWatch Database Preview

Daunorubicin hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources, and freedom to operate, for daunorubicin hydrochloride?

Daunorubicin hydrochloride is the generic ingredient in two branded drugs marketed by Fresenius Kabi Usa, West-ward Pharms Int, Teva Parenteral, Teva Pharms Usa, Sanofi Aventis Us, and Wyeth Ayerst, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.

There are eleven drug master file entries for daunorubicin hydrochloride. One supplier is listed for this compound.

Summary for Generic Name: daunorubicin hydrochloride

Tradenames:2
Patents:1
Applicants:6
NDAs:8
Drug Master File Entries: see list11
Suppliers / Packagers: see list1
Bulk Api Vendors: see list71
Clinical Trials: see list1,061
Patent Applications: see list5,509
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:daunorubicin hydrochloride at DailyMed

Pharmacology for Ingredient: daunorubicin hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Pharms Usa
DAUNORUBICIN HYDROCHLORIDE
daunorubicin hydrochloride
INJECTABLE;INJECTION065035-001Jan 24, 2000RXNoNo► Subscribe► Subscribe
Teva Parenteral
DAUNORUBICIN HYDROCHLORIDE
daunorubicin hydrochloride
INJECTABLE;INJECTION064212-002May 3, 1999DISCNNoNo► Subscribe► Subscribe
Teva Parenteral
DAUNORUBICIN HYDROCHLORIDE
daunorubicin hydrochloride
INJECTABLE;INJECTION064212-001Jun 23, 1998DISCNNoNo► Subscribe► Subscribe
Fresenius Kabi Usa
DAUNORUBICIN HYDROCHLORIDE
daunorubicin hydrochloride
INJECTABLE;INJECTION065000-001May 25, 1999RXNoNo► Subscribe► Subscribe
Wyeth Ayerst
CERUBIDINE
daunorubicin hydrochloride
INJECTABLE;INJECTION050484-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc